Spinogenix Announces Positive Type C Meeting with the FDA for SPG601 in Patients with Fragile X Syndrome (FXS)
Spinogenix has reached agreement with the FDA on important design elements for a Phase 2B/3 clinical trial of SPG601 for the treatment of FXS There Are No FDA-Approved... Read more.
From MeetRecord to Outdoo: A Name Change, A New Chapter, A Bigger Future
Rebrand reflects Outdoo’s commitment to solving revenue challenges at the source, with AI-driven roleplay, coaching, and intelligence. SAN FRANCISCO, Sept.... Read more.
Federative Republic of Brazil Announces New Bonds Offering and Tender Offer
BRASÍLIA, Brazil, Sept. 2, 2025 /PRNewswire/ — New Bonds Offering The Federative Republic of Brazil (“Brazil“) announced today the commencement... Read more.
TestingXperts Launches QXcel
Redefining Quality Engineering with GenAI and Human Trust MECHANICSBURG, Pa., Sept. 2, 2025 /PRNewswire/ — TestingXperts (Tx), a global leader in digital... Read more.
Relevant Industrial Expands Midwest Thermal Solutions Capabilities With Acquisition of Lindberg Process Equipment
HOUSTON, Sept. 2, 2025 /PRNewswire/ — Relevant Industrial, LLC (Relevant), a recognized leader in industrial equipment and engineered solutions, is pleased... Read more.
Midea to become new FC Barcelona Main Partner
World’s No. 1 smart home appliance brand signs 5-season agreement to appear on sleeve of FC Barcelona from 2026/2027 BARCELONA, Spain, Sept. 2, 2025 /PRNewswire/... Read more.
Datos Insights: SAS sets bar for vendor stability and product features in fraud and AML case management
Datos hails of SAS its ‘innovative AI/ML-powered risk scoring that delivers faster, more accurate AML outcomes’ amid surging global fraud and financial... Read more.
BingX Donates 70 Million VND in Support of Veterans and National Heroes at Long Đất Nursing Center in Vietnam
PANAMA CITY, Sept. 2, 2025 /PRNewswire/ — BingX, a leading cryptocurrency exchange and Web3 AI company, today announced the conclusion of its meaningful initiative... Read more.
Hoth Therapeutics’ Cancer Therapeutic HT-KIT Surpasses Preclinical Milestones With Potent Anti-Tumor Activity and GLP-Validated Bioanalytical Results, Exceeding Regulatory Standards
NEW YORK, Sept. 2, 2025 /PRNewswire/ — Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical innovator, today announced combined positive... Read more.
NexaMotion Group CEO Neil Sethi Honored Among Crain’s Cleveland Business Notable M&A Dealmakers
CLEVELAND, Sept. 2, 2025 /PRNewswire/ — NexaMotion Group (NMG) is pleased to announce that CEO Neil Sethi has been named among the distinguished 2025 Crain’s... Read more.